Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kyntra Bio (KYNB) Minority Interest (2016 - 2025)

Historic Minority Interest for Kyntra Bio (KYNB) over the last 12 years, with Q3 2025 value amounting to $21.5 million.

  • Kyntra Bio's Minority Interest changed 0.0% to $21.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.5 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $21.5 million for FY2024, which is 0.0% changed from last year.
  • According to the latest figures from Q3 2025, Kyntra Bio's Minority Interest is $21.5 million, which was down 0.0% from $21.5 million recorded in Q2 2025.
  • In the past 5 years, Kyntra Bio's Minority Interest ranged from a high of $21.5 million in Q2 2023 and a low of $19.3 million during Q1 2021
  • Moreover, its 5-year median value for Minority Interest was $21.5 million (2023), whereas its average is $20.7 million.
  • As far as peak fluctuations go, Kyntra Bio's Minority Interest changed by 0.0% in 2021, and later surged by 757.75% in 2023.
  • Kyntra Bio's Minority Interest (Quarter) stood at $20.0 million in 2021, then changed by 0.0% to $20.0 million in 2022, then rose by 7.58% to $21.5 million in 2023, then changed by 0.0% to $21.5 million in 2024, then changed by 0.0% to $21.5 million in 2025.
  • Its Minority Interest stands at $21.5 million for Q3 2025, versus $21.5 million for Q2 2025 and $21.5 million for Q1 2025.